|Articles|July 1, 2002
In short...
Next generation:Paradigm Medical Industries introduced its second-generation microkeratome at the American Society of Cataract and Refractive Surgery (ASCRS) meeting. The $50,000 K-Tome uses a disposable, software-driven blade the company claims will avoid the torque and wobbling associated with gear-driven systems.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Neurotrophic keratitis outcomes improve with early, stage-based care
5









































.png)


